Showing 12 out of 2322 items
- In a double-blind, placebo-controlled, randomized study called Cantos, researchers gave placebo and different doses of canakinumab (sold as Ilaris) every three ...
- Canakinumab is an antibody that is used to treat rare inflammatory conditions. It works by interfering with a receptor for the chemical signal interleukin-1b ...
- As mentioned earlier in this issue of TreatmentUpdate, the antibody canakinumab, in a study called Cantos, showed modest benefits in reducing the risk of heart ...
- As mentioned earlier in this issue of TreatmentUpdate, chronic HIV infection is associated with inflammation. Initiating HIV treatment (ART) and achieving and ...
- SIV (simian immunodeficiency virus) is closely related to HIV. In some monkeys, SIV infection causes a syndrome similar to AIDS. Researchers sometimes use ...
- A number of clinical trials are underway to study therapies that can help reduce inflammation and have other beneficial effects in people on HIV treatment ...
- One important aspect of research on inflammation in HIV is the ability to monitor inflammation. Researchers in Copenhagen, Denmark, have been studying levels of ...
- A recent study evaluated the effectiveness of a nurse navigator program in supporting engagement in care and improving clinical outcomes among veterans with HIV.
- We asked our readers to vote for their choice of the most important HIV or hepatitis C story of 2017. Here’s what you said. 10. B.C. publishes first ...
- CATIE NewsResearchers interviewed early adopters of PrEP in Toronto about their experience.. Participants reported that their use of PrEP left them feeling “proud” ...
The objective of the Canadian HIV Pregnancy Planning Guidelines is to provide clinical information and recommendations for health care providers to assist Canadians affected by HIV with their…- A study has shown that, among people living with HIV who are disengaged from care, a social network approach can successfully find and link them into HIV care.